Will modern cancer vaccines reach clinical practice? (original) (raw)
Cancer vaccines and immunotherapy
Said Dermime
British medical bulletin, 2002
View PDFchevron_right
Infection and Immunity: Novel approaches of anti-tumor vaccination based on optimal stimulation and/or rescue of immune effector cells
Roberto Accolla
2019
View PDFchevron_right
Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance
Francesco Marincola
The Journal of Immunology, 2002
View PDFchevron_right
Vaccine and antibody-directed T cell tumour immunotherapy
Said Dermime
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2004
View PDFchevron_right
Vaccination with T cell-defined antigens
Francesco Marincola
Expert Opinion on Biological Therapy, 2004
View PDFchevron_right
On the road to a tumor cell vaccine: 20 years of cellular immunotherapy
John Yannelli
Vaccine, 2004
View PDFchevron_right
ESCII–PIVAC meeting “Recent advances in cancer immunotherapy with an emphasis on cancer vaccines” held in Athens, 9–11 October 2008
Viktor Umansky
Cancer Immunology, Immunotherapy, 2010
View PDFchevron_right
Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine
Mario Colombo
Gene Therapy, 1999
View PDFchevron_right
Cellular and humoral immune responses against cancer: implications for cancer vaccines
Mauricio Jose Rodrigues
Current Opinion in Immunology, 1991
View PDFchevron_right
Induce Potent Antitumor Immunity T Cells and + Cross-Presented to CD8 Surface of Liposomes Are Antigen Chemically Coupled to the
Yuriko Tanaka
2000
View PDFchevron_right
Antigens recognized on human tumors by cytolytic T lymphocytes: Towards vaccinationq
Etienne Plaen
European Journal of Cancer, 1995
View PDFchevron_right
Antigen Presented by TumorsIn vivoDetermines the Nature of CD8+ T-Cell Cytotoxicity
Anil Shanker
Cancer Research, 2009
View PDFchevron_right
Cancer immunotherapy: moving beyond current vaccines
James Yang
Nature Medicine, 2004
View PDFchevron_right
The Immunization Site of Cytokine-Secreting Tumor Cell Vaccines Influences the Trafficking of Tumor-Specific T Lymphocytes and Antitumor Efficacy against Regional Tumors
Lih-hwa Hwang
The Journal of Immunology, 2004
View PDFchevron_right
Requirement of tumor-associated antigen-specific CD4+ T cells for an efficient dendritic cell vaccine in antitumor immunotherapy
Marc Grégoire
2013
View PDFchevron_right
Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines
Suzanne L Elliott
European Journal of Immunology, 2000
View PDFchevron_right
Heteroclitic Immunization Induces Tumor Immunity
Paul Szabo
Journal of Experimental Medicine, 1998
View PDFchevron_right
Genetically modified tumour vaccines – where we are today
Andrzej Mackiewicz, Sergiusz Nawrocki
Cancer Treatment Reviews, 1999
View PDFchevron_right
Therapeutic cancer vaccines based on molecularly defined human tumor antigens
Pedro Romero
Vaccine, 2002
View PDFchevron_right
Antigen Presented by Tumors In vivo Determines the Nature of CD8+ T-Cell Cytotoxicity
Anil Shanker
Cancer Research, 2009
View PDFchevron_right
Supplementary Figure 1 from Antigen Presented by Tumors <i>In vivo</i> Determines the Nature of CD8<sup>+</sup> T-Cell Cytotoxicity
Anil Shanker
2023
View PDFchevron_right
Immune monitoring of cancer vaccines: Report on a workshop held at the 9th NCI-EORTC Symposium on New Drugs in Cancer Therapy
Vladia Monsurro
Annals of Oncology, 1996
View PDFchevron_right
Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK
Graham Pawelec
Cancer Immunology, Immunotherapy, 2002
View PDFchevron_right
Cancer Vaccines and T Cell Therapy
Debra K Czerwinski
Biology of Blood and Marrow Transplantation, 2013
View PDFchevron_right
Tumor-Specific CD4+ T Cells Are Activated by "Cross-Dressed" Dendritic Cells Presenting Peptide-MHC Class II Complexes Acquired from Cell-Based Cancer Vaccines
S. Ostrand-rosenberg
The Journal of Immunology, 2006
View PDFchevron_right
Allogeneic tumor cell vaccines
Imade Imasuen, Periasamy Selvaraj, Jaina Patel
Http Dx Doi Org 10 4161 Hv 26568, 2013
View PDFchevron_right
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Kimberly Schluns
Nature Medicine, 2013
View PDFchevron_right
Cytotoxic T cells and Cancer Therapy
Sandip Chakraborty
Journal of Experimental Biology and Agricultural Sciences, 2017
View PDFchevron_right
Antigen-Presenting Cell/Tumour Cell Hybrid Vaccines in Cancer Immunotherapy
Yehia S Mohamed
Immunotherapy - Myths, Reality, Ideas, Future
View PDFchevron_right
Enhancement of Tumor Outgrowth Through CTL Tolerization After Peptide Vaccination Is Avoided by Peptide Presentation on Dendritic Cells
Martin Kast
The Journal of Immunology, 1998
View PDFchevron_right
T-cell immunotherapy of cancer
Cornelis Melief
View PDFchevron_right
Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune responsein vivo
Tim Greten
International Journal of Cancer, 2003
View PDFchevron_right